All current DZIF news can be found here.

© Universität Tübingen / Paul Mehnert

Tübingen study raises hope for effective malaria vaccine

At the University Hospital of Tübingen, a clinical trial led by Prof. Dr. Peter Kremsner, Director of the Institute of Tropical Medicine, Travel Medicine and Human Parasitology and Dr. Rolf Fendel

Kamele in Dubai

MERS coronavirus: Vaccine development is going into the next round

In addition to the SARS coronavirus-2 that is currently prevalent worldwide, scientists continue to keep an eye on the related MERS coronavirus, as it, too, could potentially become a supra-regional

Hans-Peter Grobbel
© FZ Borstel

Tailor-made therapy of multi-resistant tuberculosis

The successful treatment of multidrug-resistant tuberculosis requires clarification in advance as to which antibiotics the pathogens are resistant to. Classic testing in the laboratory is very time

Struktur SUD Paip1
© J. Lei et al., 2021, EMBO Journal

How SARS-coronaviruses reprogram the human cell to their own benefit

DZIF scientists Prof. Rolf Hilgenfeld of the University of Lübeck and Dr. Albrecht von Brunn of the Ludwig-Maximilians University of Munich  discovered how SARS viruses enhance the production of viral

© Sonja Taut / MPI of Biochemistry

A multidimensional view of the coronavirus

What exactly happens when the corona virus SARS-CoV-2 infects a cell? In an article published in Nature, a team from the Technical University of Munich (TUM) and the Max Planck Institute of

Coronaviren als Bedrohung
© Tumisu auf Pixabay

Will COVID-19 vaccines need to be adapted regularly?

Influenza vaccines need to be evaluated every year to ensure they remain effective against new influenza viruses. Will the same apply to COVID-19 vaccines? In order to gauge whether and to what extent

© Rasche

Hepatitis B: What people can learn from donkeys

The discovery of a previously unknown hepatitis B virus in donkeys and zebras opens up new opportunities for understanding the course of the disease. A global research consortium was able to show that

Christoph Lange untersucht einen Patienten

Tuberculosis: New biomarker indicates individual treatment duration

The treatment of tuberculosis (TB) is long, demanding, and expensive. In particular, the ever increasing emergence of resistant tuberculosis bacteria requires a lot of patience: In these cases, the

Hepatitis E virus
© Gadicherla und Johne, BfR, 2020

Hepatitis E viruses surviving in the ejaculate of chronically infected patients

Hepatitis E is an infectious disease of the liver found across the globe. It is caused by the hepatitis E virus and in most cases heals by itself. However, in patients with a suppressed immune system

Hepatitis B virions (orange coloured)
© CDC/Dr. Erskine Palmer

New combination therapy offers chance of healing hepatitis B

Around 260 million people, more than three percent of the global population, are chronically infected with the hepatitis B virus (HBV); in the long term, this often leads to complications such as